Exelixis (EXEL) EBIT (2016 - 2026)
Historic EBIT for Exelixis (EXEL) over the last 17 years, with Q1 2026 value amounting to $235.2 million.
- Exelixis' EBIT rose 4412.22% to $235.2 million in Q1 2026 from the same period last year, while for Jan 2026 it was $872.2 million, marking a year-over-year increase of 4425.51%. This contributed to the annual value of $872.2 million for FY2026, which is 4425.51% up from last year.
- According to the latest figures from Q1 2026, Exelixis' EBIT is $235.2 million, which was up 4412.22% from $236.5 million recorded in Q4 2025.
- Exelixis' EBIT's 5-year high stood at $275.9 million during Q2 2024, with a 5-year trough of -$48.1 million in Q4 2022.
- In the last 5 years, Exelixis' EBIT had a median value of $83.5 million in 2022 and averaged $115.6 million.
- Data for Exelixis' EBIT shows a peak YoY increase of 190688.08% (in 2022) and a maximum YoY decrease of 14073.68% (in 2022) over the last 5 years.
- Over the past 5 years, Exelixis' EBIT (Quarter) stood at -$48.1 million in 2022, then soared by 270.12% to $81.8 million in 2023, then skyrocketed by 66.38% to $136.1 million in 2024, then skyrocketed by 73.83% to $236.5 million in 2025, then dropped by 0.56% to $235.2 million in 2026.
- Its EBIT stands at $235.2 million for Q1 2026, versus $236.5 million for Q4 2025 and $213.6 million for Q3 2025.